Company Profile

Fzata Inc
Profile last edited on: 2/22/2023      CAGE: 7HCP9      UEI: SLGDVHJS1Y85

Business Identifier: Novel platform modality for oral biologics: Bioengineered Probiotic Yeast Medicines (BioPYM) with over 10 GI drug candidates
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1448 South Rolling Road Suite 120
Halethorpe, MD 21227
   (443) 543-5040
Location: Single
Congr. District: 03
County: Baltimore

Public Profile

FZata, Inc. is usefully understood as an antibody technology company organized around development of antibody-based therapeutic and preventive medicines utilizing the power of human immunity of antibodies for applications against diseases. Activating the Human Protective Antibody Platform, the effort is to develop antibody from human B cells •Pure human antibody from naturally selected B cells for natural targets •Enable high-throughput screening for functional antibody •High success rate and highly efficient •Proprietary, state-of-the-art & versatile •Successfully applied in developing antibodies against HIV, C. difficile & Hepatitis B virus. The firm's first-in-class Bioengineered Probiotic Yeast Medicines (BioPYM™) platform is a novel oral administration modality for biologics. Fzata's vision is to replace needle administration of biologics for sufferers of gastrointestinal disorders with a capsule.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Zhiyong Yang -- Co-founder & CEO

  Hanping Feng -- Co-Founder & Chief Scientific Consultant

  Elizabeth Smith -- Chief Business Officer

  Jibin Zhao -- Master On Food Engineering, Mba

Company News

There are no news available.